Medindia

X

Review of Naltrexone Implants Sought Due to Severe Adverse Reactions

by VR Sreeraman on  April 20, 2008 at 2:30 PM Alcohol & Drug Abuse News   - G J E 4
Review of Naltrexone Implants Sought Due to Severe Adverse Reactions
An urgent review of the use of naltrexone (including implants) for opioid dependence is needed following reports of severe adverse reactions, according to two articles in the latest Medical Journal of Australia.
Advertisement

In its editorial, Associate Professor Robert Ali, Director of the Drug Alcohol Services Council in Adelaide, and his co-authors said that naltrexone is theoretically an attractive treatment for opioid dependence because it is inexpensive, long-acting, and generally well tolerated.

Advertisement
Oral naltrexone is used as a treatment for heroin and alcohol dependence.

However, the effectiveness and safety of oral treatments is compromised by poor patient adherence to taking regular doses. This has led to the development of long-acting naltrexone implants and depot injections.

Naltrexone implants have not been approved for human use in Australia, but these implants are being supplied through some private clinics.

Assoc. Prof. Ali says that naltrexone implants are currently obtained through the TGA Special Access Scheme but without the product being subjected to the usual rigorous scrutiny required for new devices in Australia.

"It is concerning that the recent research on naltrexone implants in Australia has not followed usual scientific processes," he said.

In a related study published in the journal, Dr Paul Haber, Head of Drug Health Services at Royal Prince Alfred Hospital, and his co-authors studied 12 patients who were admitted to hospital soon after receiving naltrexone in oral or implant form.

Eight of the cases were definitely or probably related to the naltrexone implant, including cases of severe opiate withdrawal and dehydration, infection at the implant site requiring surgery, and a psychiatric disorder.

The authors said these severe adverse events challenge the notion that naltrexone implants are a safe procedure.

"These events suggest a need for careful case selection, careful clinical management, and for closer regulatory monitoring to protect this marginalised and vulnerable population," Dr Haber said.

"Patients should be warned of the associated risks, and appropriate procedures planned to respond to any complications."

Dr Haber also emphasises the importance of screening patients for underlying medical or psychiatric conditions and, importantly, coordinating with relevant service providers.

"Similarly, a close relationship between naltrexone implant providers and local emergency departments is important."

"The widespread and unregulated use of naltrexone implants without appropriate safeguards for patients, their families and service providers should be restricted until this therapeutic product has been assessed for safety and effectiveness," he said.

The Medical Journal of Australia is a publication of the Australian Medical Association.

Source: MJA
SRM/C
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Any way you look at it, Human experimentation is illegal without consent.

Fraudulantly selling a procedure is also illegal.

I buried a healthy clean son 10 yrs ago who got the implant to " stop cravings" and "end addiction". in 2 short months , it ended his life.

He got the death penalty for doing the right thing in seekiing treatment for addiction.

He was buried as an "accidental overdose" with no mention of the Naltrexone implant in autospy.

Gooberman killed more then 7 patients.

guest Wednesday, April 23, 2008

You May Also Like

Advertisement
View All